Oscar Renda Contracting & Johnson Brothers Corp to Sell Idle Assets on AllSurplus.com Online Marketplace
April 27, 2020 16:02 ET
|
Liquidity Services, Inc.
BETHESDA, Md., April 27, 2020 (GLOBE NEWSWIRE) -- Oscar Renda Contracting & Johnson Brothers Corp is selling its idle equipment through online auction marketplace, www.AllSurplus.com. AllSurplus...
Mid Penn Bancorp, Inc. Reports First Quarter 2020 Earnings and Declares a Quarterly Dividend
April 27, 2020 16:01 ET
|
Mid Penn Bancorp
MILLERSBURG, Pa., April 27, 2020 (GLOBE NEWSWIRE) -- Mid Penn Bancorp, Inc. (“Mid Penn”) (NASDAQ: MPB), the parent company of Mid Penn Bank (the “Bank”), today reported net income to common...
Aeglea BioTherapeutics Announces Proposed Public Offering
April 27, 2020 16:01 ET
|
Aeglea BioTherapeutics, Inc.
AUSTIN, Texas, April 27, 2020 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (Nasdaq: AGLE), a clinical-stage biotechnology company developing next-generation human enzyme therapeutics as...
NeuBase Therapeutics Announces Proposed Public Offering of Common Stock
April 27, 2020 16:01 ET
|
NeuBase Therapeutics, Inc.
PITTSBURGH, April 27, 2020 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE), a preclinical-stage biotechnology company focused on developing next generation therapies to treat rare...
CN Delivers Solid First Quarter Results Despite Network Disruptions
April 27, 2020 16:01 ET
|
Canadian National Railway
Railroad demonstrates resiliency with solid performance amidst month-long illegal blockades and impacts of the COVID-19 pandemic MONTREAL, April 27, 2020 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE:...
Heartland Financial USA, Inc. Reports Quarterly Results as of March 31, 2020
April 27, 2020 16:01 ET
|
Heartland Financial USA, Inc.
Highlights and Developments Quarterly net income of $20.0 million or $0.54 per diluted common share in comparison with $31.5 million or $0.91 per diluted common share for the first quarter of...
Iovance Biotherapeutics to Host First Quarter 2020 Financial Results Conference Call and Webcast on Tuesday, May 5, 2020
April 27, 2020 16:01 ET
|
Iovance Biotherapeutics, Inc.
SAN CARLOS, Calif., April 27, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, will...
I-Mab and MorphoSys Announce First Patient Dosed in Phase 3 Clinical Trial of TJ202/MOR202 in r/r Multiple Myeloma in Mainland China
April 27, 2020 16:01 ET
|
I-Mab
SHANGHAI, China, and ROCKVILLE, Md., and MUNICH, Germany, April 27, 2020 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development...
Immunomedics Announces Proposed Public Offering Of Common Stock
April 27, 2020 16:01 ET
|
Immunomedics
MORRIS PLAINS, N.J., April 27, 2020 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug...
Waterstone Financial, Inc. Announces Change to a Virtual-Only Format for 2020 Annual Meeting of Shareholders
April 27, 2020 16:01 ET
|
Waterstone Financial, Inc.
WAUWATOSA, Wis., April 27, 2020 (GLOBE NEWSWIRE) -- Waterstone Financial, Inc. (NASDAQ: WSBF), announced today a change in the location of its 2020 Annual Meeting of Shareholders (the “2020 Annual...